Clinical ethics committee case 9: should we inform our patient about animal products in his medicine?

Dublin Core

Title

Clinical ethics committee case 9: should we inform our patient about animal products in his medicine?

Author

Newson, Ainsley J.

Publisher

2010/03/00

Language

English

Publication Date

20100300

Primary Classification

9.7

Secondary Classification

9.7;1.2;8.3.1;9.5.1;9.6;22.1

Primary keywords

disclosure--[pri];drugs--[pri];hospitals--[pri];informed consent--[pri];institutional ethics--[pri];moral obligations--[pri];Muslims--[pri];patients--[pri];religiously prohibited materials--[pri];values--[pri]

Secondary keywords

alternatives;autonomy;clinical ethics committees;cultural pluralism;ethics consultation;Islamic councils;legal obligations;moral policy;motivation;organizational policies;pharmacists;preventive medicine;religion;resource allocation;selection for treatment

Subject

Clinical Ethics Advisory Group (University Hospitals Bristol NHS Foundation Trust--[pri]

Subject

Great Britain;Muslim Council of Britain;Vegetarian Council (Great Britain)

Subject

heparin--[pri]

Subject

vegetarianism

Journal Article

Clinical Ethics 2010 March; 5(1): 7-12 [Online]. Accessed: http://ce.rsmjournals.com/cgi/reprint/5/1/7 [ 2010 December 15]

Primary Document Type

ja

Call Number

citation

Subject Captions

cs

Bibliography

10 fn.

Collection

IMSE Database

Citation

“Clinical ethics committee case 9: should we inform our patient about animal products in his medicine?,” Islamic Medical & Scientific Ethics, accessed July 27, 2024, http://imse.ibp.georgetown.domains/items/show/34664.